Andexanet alfa for reversing anticoagulation: Final appraisal document

In DRAFT guidance, NICE recommends andexanet alfa as an option for reversing anticoagulation from apixaban or rivaroxaban in adults with life-threatening or uncontrolled bleeding in the gastrointestinal tract, if the company provides it according to the commercial arrangement.

Source:

National Institute for Health and Care Excellence